Clinical Trials · NCT00361595
Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- The Cleveland Clinic
- Enrollment
- 35
- Start date
- Aug 2006
- Locations
- 1 site, United States
- Primary endpoint
- Change in Lumbar Spine BMD (Bone Mineral Density) in g/cm^2 From Baseline to Month 12 Relative to Baseline as Measured by DXA (Dual-energy X-ray Absorptiometry)